COVID-19 Updates
Latest News
Pandemic caused treatment delay for half of patients with CTCL, study finds
No clinical trials exist to inform maintenance protocols in patients with cutaneous lymphomas.
Feature
More vaccinated people dying of COVID as fewer get booster shots
But the case for the effectiveness of vaccines and boosters versus skipping the shots remains strong.
Feature
Without guidelines, docs make their own long-COVID protocols
Treating the condition requires equal combinations of skill, experience, and intuition. Doctors begin to cobble together treatment plans.
Latest News
The right indoor relative humidity could ward off COVID
The “sweet spot” associated with reduced COVID-19 cases and deaths is 40%-60% indoor relative humidity.
From the Journals
Hypertension linked to risk of severe COVID
A new study out of the United Kingdom identifies at what level high blood pressure can help predict a life-threatening case of the virus.
News
‘A huge deal’: Millions have long COVID, and more are expected
More than a quarter say their condition is severe enough to significantly limit their day-to-day activities.
From the Journals
Third COVID booster benefits cancer patients
For the first time, researchers have quantified the benefits of boosters for COVID-19 in cancer patients.
Conference Coverage
No benefit of rivaroxaban in COVID outpatients: PREVENT-HD
PREVENT-HD joins a long list of smaller trials also showing no benefit of anticoagulation in nonhospitalized COVID-19 patients.
Livin' on the MDedge
Have you heard the one about the emergency dept. that called 911?
Plus: LDL cholesterol unimpressed by heart-healthy supplements, and college students emboldened by negative COVID tests.
Feature
Working while sick: Why doctors don’t stay home when ill
Only 2% of respondents said they never come to work unwell, in a Medscape survey.
From the Journals
Original COVID-19 vaccines fall short against Omicron subvariants for the immunocompromised
Findings from a CDC-supported study suggest that updated, bivalent boosters targeting recently circulating Omicron subvariants may benefit adults...